May 26, 2022

FDA Updates Contrast Shortage Posting to Include Estimated Shortage Duration

The U.S. Food and Drug Administration (FDA) has updated its drug shortage postings for and to reflect product availability updates, including estimated shortage duration forecasts.

Most presentations forecast supply increasing through May and June, with a return to stocking levels by July. The FDA’s postings also include a link to a from GE Healthcare’s CEO.

Bayer’s has also been added to the FDA’s Drug shortage page resulting from increased demand likely related to the GE shortage issues.

The 新澳门六合彩官网® (新澳门六合彩官网®) has developed a resource page on the contrast media shortage. For more information, please contact Gloria Romanelli, JD, 新澳门六合彩官网 Senior Director, Legislative and Regulatory Relations.